Samsung Bioepis’ new autoimmune disease treatment hits European market
Samsung Bioepis Co., a biosimilar medicine developer under Samsung Group, has released its biosimilar product for autoimmune disease treatment Stelara in Europe, the company’s marketing partner said Friday.
Pyzchiva, a treatment for plaque psoriasis…
